Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review
Pharmacoeconomics and Policy · 2026-03 · 2 (1) · 4-11
DOI: 10.1016/j.pharp.2026.03.002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pharmacoeconomics and Policy, 2026-03. Verfasst von Saba Abidi und 4 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abidi, S., Dwivedi, S., Sharma, V., Kumar, A., & Talegaonkar, S. (2026). Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review. Pharmacoeconomics and Policy, 2(1), 4-11. https://doi.org/10.1016/j.pharp.2026.03.002
Vancouver
Abidi S, Dwivedi S, Sharma V, Kumar A, Talegaonkar S. Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review. Pharmacoeconomics and Policy. 2026;2(1):4-11. doi:10.1016/j.pharp.2026.03.002
BibTeX
@article{Abidi2026,
author = {Abidi, Saba and Dwivedi, Shridhar and Sharma, Vinod and Kumar, Anoop and Talegaonkar, Sushama},
title = {Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review},
journal = {Pharmacoeconomics and Policy},
year = {2026},
volume = {2},
number = {1},
pages = {4--11},
doi = {10.1016/j.pharp.2026.03.002}
}
EUVIMED